EBITDA for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's current EBITDA (TTM) is $158.38B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$158.38B
YoY change
+5.9%
5Y CAGR
+21.5%
Peak year (2025)
$156.73B
Cumulative EBITDA
$1.16T
EBITDA history chart for Novo Nordisk (NVO) from 1985 to 2025
EBITDA history table for Novo Nordisk (NVO) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $156.73B | +5.9% | ||
| 2024 | $147.94B | +29.1% | ||
| 2023 | $114.63B | +49.3% | ||
| 2022 | $76.80B | +17.4% | ||
| 2021 | $65.39B | +10.3% | ||
| 2020 | $59.27B | +8.9% | ||
| 2019 | $54.43B | +5.4% | ||
| 2018 | $51.63B | -0.6% | ||
| 2017 | $51.95B | +1.8% | ||
| 2016 | $51.06B | +9.8% | ||
| 2015 | $46.51B | +23.8% | ||
| 2014 | $37.57B | +6.2% | ||
| 2013 | $35.39B | +15.8% | ||
| 2012 | $30.56B | +22.6% | ||
| 2011 | $24.94B | +17.3% | ||
| 2010 | $21.25B | +19.4% | ||
| 2009 | $17.80B | +19.8% | ||
| 2008 | $14.86B | +24.1% | ||
| 2007 | $11.97B | +6.3% | ||
| 2006 | $11.26B | +12.6% | ||
| 2005 | $10.00B | +12.0% | ||
| 2004 | $8.93B | +11.3% | ||
| 2003 | $8.02B | +9.8% | ||
| 2002 | $7.30B | +9.4% | ||
| 2001 | $6.67B | +26.5% | ||
| 2000 | $5.28B | +36.5% | ||
| 1999 | $3.87B | +59.8% | ||
| 1998 | $2.42B | -30.4% | ||
| 1997 | $3.48B | +14.1% | ||
| 1996 | $3.05B | +1.2% | ||
| 1995 | $3.01B | +4.0% | ||
| 1994 | $2.90B | +5.5% | ||
| 1993 | $2.74B | +48.1% | ||
| 1992 | $1.85B | -7.2% | ||
| 1991 | $2.00B | +26.9% | ||
| 1990 | $1.57B | +3.4% | ||
| 1989 | $1.52B | +20.8% | ||
| 1988 | $1.26B | +37.9% | ||
| 1987 | $913.87M | +2.3% | ||
| 1986 | $893.58M | -4.2% | ||
| 1985 | $933.15M | — |
EBITDA values are taken from Novo Nordisk's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
As of the 2025 fiscal year, Novo Nordisk (NVO) reported EBITDA of $156.73B – grew 5.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Novo Nordisk EBITDA compounded at +21.5% per year, sustaining 7 straight years of year-over-year growth.
The dataset's maximum EBITDA sits at $156.73B (2025); the minimum reading of $893.58M dates to 1986.
Novo Nordisk (NVO) sits 1st of 8 Healthcare peers we track on this metric, against a peer median of $21.44B.
Novo Nordisk EBITDA by Year
Novo Nordisk EBITDA 2025: $156.73B
Novo Nordisk EBITDA in 2025 was $156.73B, grew 5.9% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk EBITDA 2024: $147.94B
Novo Nordisk EBITDA in 2024 was $147.94B, grew 29.1% from 2023.
Novo Nordisk EBITDA 2023: $114.63B
Novo Nordisk EBITDA in 2023 was $114.63B, surged 49.3% from 2022.
Novo Nordisk EBITDA 2022: $76.80B
Novo Nordisk EBITDA in 2022 was $76.80B, grew 17.4% from 2021.
Novo Nordisk EBITDA 2021: $65.39B
Novo Nordisk EBITDA in 2021 was $65.39B.
See more financial history for Novo Nordisk (NVO).
Sector peers — EBITDA
Companies in the same sector as Novo Nordisk, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $11.47B | Healthcare |
Frequently asked questions
What is Novo Nordisk's EBITDA?
- Latest reported EBITDA for Novo Nordisk (NVO) is $158.38B (period ending December 31, 2025).
How has Novo Nordisk EBITDA changed year-over-year?
- Novo Nordisk (NVO) EBITDA changed +5.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk EBITDA?
- Novo Nordisk (NVO) EBITDA compound annual growth rate is +21.5% over the most recent 5 years available.
When did Novo Nordisk EBITDA hit its highest annual value?
- Novo Nordisk EBITDA reached its highest annual value of $156.73B in 2025.
What was Novo Nordisk EBITDA in 2024?
- Novo Nordisk (NVO) EBITDA in 2024 was $147.94B.
What was Novo Nordisk EBITDA in 2025?
- Novo Nordisk (NVO) EBITDA in 2025 was $156.73B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.